Laurion Capital Management LP Bio Xcel Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $2.38 Million - $3.2 Million	-100,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $2.91 Million - $3.88 Million	100,000 New	100,000 $2.91 Million
Q2 2020 Aug 14, 2020	SELL	$17.62 - $58.71 $528,600 - $1.76 Million	-30,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $367,800 - $1.23 Million	30,000 New	30,000 $671,000
Q3 2018 Nov 13, 2018	SELL	$7.51 - $12.99 $75,100 - $129,900	-10,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$9.83 - $11.03 $98,300 - $110,300	10,000 New	10,000 $102,000

3.06M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $83.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.